Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Identifying patients with therapy-resistant depression by using factor analysis.

Andreasson K, Liest V, Lunde M, Martiny K, Unden M, Dissing S, Bech P.

Pharmacopsychiatry. 2010 Nov;43(7):252-6. doi: 10.1055/s-0030-1263166. Epub 2010 Sep 6.

PMID:
20821367
2.

Transcranial magnetic stimulation for medication-resistant depression.

Yip AG, Carpenter LL.

J Clin Psychiatry. 2010 Apr;71(4):502-3. doi: 10.4088/JCP.10ac06054blu. No abstract available.

PMID:
20409447
3.

High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: a prospective 4-week naturalistic trial.

Berlim MT, McGirr A, Beaulieu MM, Turecki G.

J Affect Disord. 2011 Apr;130(1-2):312-7. doi: 10.1016/j.jad.2010.10.011. Epub 2010 Nov 5.

PMID:
21056475
4.

Combined VNS-rTMS treatment in a patient with therapy resistant depression.

Sperling W, Kornhuber J, Wiltfang J, Bleich S.

Pharmacopsychiatry. 2007 Jan;40(1):39-40. No abstract available.

PMID:
17327961
5.

Identifying "paradigm failures" contributing to treatment-resistant depression.

Parker GB, Malhi GS, Crawford JG, Thase ME.

J Affect Disord. 2005 Aug;87(2-3):185-91.

PMID:
15979725
6.

Assessing onset of treatment benefit in depression and anxiety: conceptual considerations.

Laska EM, Mallinckrodt CH, Mundt JC, Leber P, Vaccarino AL, Kalali AH, Greist JH.

J Clin Psychiatry. 2009 Aug;70(8):1138-45. doi: 10.4088/JCP.09cs05129.

PMID:
19758524
7.

Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression.

Schatzberg AF, Kraemer HC.

Biol Psychiatry. 2000 Apr 15;47(8):736-44.

PMID:
10773182
8.

Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression.

Loo CK, Mitchell PB, Croker VM, Malhi GS, Wen W, Gandevia SC, Sachdev PS.

Psychol Med. 2003 Jan;33(1):33-40.

PMID:
12537034
9.

Easing the burden of treatment-resistant depression.

[No authors listed]

J Clin Psychiatry. 2009 Feb;70(2):273-80. No abstract available.

PMID:
19265643
10.

Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome.

Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F, Lerer B, Zangen A.

J Affect Disord. 2011 Feb;128(3):235-42. doi: 10.1016/j.jad.2010.06.038. Epub 2010 Jul 21.

PMID:
20663568
11.

Treatment-resistant depression in Hispanic patients.

Podawiltz A, Culpepper L.

J Clin Psychiatry. 2010 Jun;71(6):e12. doi: 10.4088/JCP.8153tx3cc. Review.

12.
13.

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.

J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.

PMID:
19027961
14.

Anxious versus non-anxious depression: difference in treatment outcome.

Domschke K, Deckert J, Arolt V, Baune BT.

J Psychopharmacol. 2010 Apr;24(4):621-2. doi: 10.1177/0269881108097723. Epub 2008 Oct 6. No abstract available.

PMID:
18838496
15.

Methylphenidate and depression.

Ng B.

J Clin Psychopharmacol. 2008 Feb;28(1):116-7; author reply 117-8. doi: 10.1097/jcp.0b013e3181603f38. No abstract available.

PMID:
18204360
16.

Antidepressant response and subthreshold bipolarity in "unipolar" major depressive disorder: implications for practice and drug research.

Rihmer Z, Dome P, Gonda X.

J Clin Psychopharmacol. 2013 Aug;33(4):449-52. doi: 10.1097/JCP.0b013e318299d2d5. No abstract available.

PMID:
23775059
17.

Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.

Nelson JC, Delucchi K, Schneider LS.

Int J Geriatr Psychiatry. 2009 May;24(5):539-44. doi: 10.1002/gps.2233.

PMID:
19334041
18.

Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression.

Martiny K, Lunde M, Bech P.

Biol Psychiatry. 2010 Jul 15;68(2):163-9. doi: 10.1016/j.biopsych.2010.02.017. Epub 2010 Apr 10.

PMID:
20385376
19.

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.

Arch Gen Psychiatry. 2004 Dec;61(12):1235-44.

PMID:
15583115
20.

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.

Avery DH, Holtzheimer PE 3rd, Fawaz W, Russo J, Neumaier J, Dunner DL, Haynor DR, Claypoole KH, Wajdik C, Roy-Byrne P.

Biol Psychiatry. 2006 Jan 15;59(2):187-94. Epub 2005 Sep 1.

PMID:
16139808

Supplemental Content

Support Center